The people I've spoken to tell me that the "Wheezometer" has ZERO CLINICAL NEED. I take the passer's by comments (and all under ASX release) at the booths at the conference with a really BIG grain of salt!Best of luck
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025